As of May 23, 2025, United Therapeutics Corp (UTHR) reports a Graham Number of 291.81.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of United Therapeutics Corp's Graham Number
Over recent years, United Therapeutics Corp's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 291.81 |
| 2023-12-31 | 255.28 |
| 2022-12-31 | 196.40 |
| 2021-12-31 | 144.32 |
| 2020-12-31 | 139.02 |
This steady improvement highlights how United Therapeutics Corp manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing United Therapeutics Corp's Graham Number to Peers
To better understand United Therapeutics Corp's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| United Therapeutics Corp (UTHR) | 291.81 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Emergent BioSolutions Inc (EBS) | 57.84 |
| CRISPR Therapeutics AG (CRSP) | 57.41 |
Compared to its competitors, United Therapeutics Corp's Graham Number is among the highest compared to peers, suggesting potentially stronger fundamental value according to Graham's principles.